Medcast news and blog
Wearables and AF: how smart are smartwatches?
Wearables with PPG or ECG capabilities can identify episodes of irregular heart rhythms suggestive of AF, but should not replace traditional methods of diagnosis, such as a 12-lead ECG. Evidence of accuracy and positive predictive values from prospective, comparative trials involving older populations are limited, and the potential for inconclusive results remains a concern based on current trial findings. Their utility may be highest for symptomatic individuals or those at risk of developing AF.
READ ON
This is the second FastTrack on atrial fibrillation (AF). Part 1 described the diagnosis, initial assessment of AF, and indications for urgent review. This FastTrack describes the approach to setting a management strategy using risk calculators, how to assess and reduce risk factors, and long term monitoring of patients with AF.
Atrial fibrillation (AF) is common and significantly impacts mortality, contributing to as many as 1 in 10 deaths in Australia. This FastTrack is the first of two, focusing on the diagnosis and management of AF, from the recommendations on opportunistic screening to identifying comorbidities and precipitating factors. Complete the quiz to earn 30mins EA and 30mins RP CPD.
Too many patients with atrial fibrillation (AF) and an elevated risk of stroke are missing out on appropriate long-term anticoagulation, and this puts them at unacceptable risk of catastrophic stroke and death. This makes early detection, use of validated stroke and bleeding risk assessment tools, and prompt initiation of anticoagulation essential.